Svenska  |  Site map  |  Contact

Moberg Pharma AB (publ.), is a rapidly growing Swedish pharmaceutical company with direct sales in the USA and through distributors in more than 35 countries. The product portfolio includes topical products for treatment of skin diseases and pain.

Moberg Pharma was founded by Peter Wolpert and Marie Moberg, and is based on many years of research by the Swedish dermatologist Dr Sven Moberg, who worked at Sahlgrenska University Hospital. The company's portfolio has since been expanded to include new innovations as well as in-licensed and acquired products and projects. The product and project portfolio includes pharmaceuticals, medical device products and self-care products.

Business model
Moberg Pharmas business modelincludes direct sales as well as sales through distributors and partners. The company’s product development is based on innovative drug delivery of proven compounds which reduce time to market, development cost and risk compared with traditional drug development.

The share of Moberg Pharma is quoted on the Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm.

Links

 Contact
 Emtrix
Kerasal
JointFlex
 Kaprolac
 Press releases
Moberg Pharma AB (publ)
Gustavslundsvägen 42, 5 tr, 167 51 Bromma
Telefon: 08-522 30 700
info@mobergphama.se